product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
CD44 (156-3C11) Mouse mAb (PE Conjugate)
catalog :
8724
clonality :
monoclonal
host :
mouse
conjugate :
PE
clone name :
156-3C11
reactivity :
human
application :
flow cytometry
citations: 3
Reference
Zeng J, Ruan J, Luo L, Shi J, Cui Q, Yang J, et al. Molecular portraits of heterogeneity related to cancer stem cells in human ovarian cancer. Int J Gynecol Cancer. 2014;24:29-35 pubmed publisher
Nanashima A, Hatachi G, Tsuchiya T, Matsumoto H, Arai J, Abo T, et al. Clinical significances of cancer stem cells markers in patients with intrahepatic cholangiocarcinoma who underwent hepatectomy. Anticancer Res. 2013;33:2107-14 pubmed
Iida J, Dorchak J, Lehman J, Clancy R, Luo C, Chen Y, et al. FH535 inhibited migration and growth of breast cancer cells. PLoS ONE. 2012;7:e44418 pubmed publisher
product information
SKU :
8724S
Product-Name :
CD44 (156-3C11) Mouse mAb (PE Conjugate)
Size :
100 ul
Price-(USD) :
291 USD
Species-x-Reactivity :
H
Applications :
Flow cytometry
Product-Category :
Immunology and Inflammation
Shipping-Temp :
COLD
Storage-Temp :
4°C
Product-Type :
Monoclonal Antibody
Host :
Mouse
Target :
CD44
Primary-Protein :
CD44
Alt-Names :
CD44,CD44 antigen,CD44 antigen (homing function and Indian blood group system),CD44 molecule (Indian blood group),CDW44 antigen,CDw44,CSPG8,ECMR-III,Epican,Extracellular matrix receptor III,GP90 lymphocyte homing/adhesion receptor,HCELL,HUTCH-I,Heparan sulfate proteoglycan,Hermes antigen,Hyaluronate receptor,IN,LHR,MC56,MDU2,MDU3,MGC10468,MIC4,MUTCH-I,PGP-1,PGP-I,Pgp1,Phagocytic glycoprotein 1,Phagocytic glycoprotein I,antigen gp90 homing receptor,cell adhesion molecule,cell surface glycoprotein CD44,chondroitin sulfate proteoglycan 8,extracellular matrix receptor-III,hematopoietic cell E- and L-selectin ligand,homing function and Indian blood group system
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.